| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $11.18M | -2,034 | |
| VP | 109.2K | $5.42M | - | |
| VP | 69.4K | $3.44M | -9,000 | |
| Dir | 43.3K | $2.15M | -44,472 | |
| CFO | 36.7K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2022 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 347,257 | $27.98 | $9,717,783.63 | -10.8% | -6.3% | +6.6% | |
| May 3, 2022 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $28.62 | $715,415.00 | -9.7% | -13.2% | -1.2% | |
| May 2, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $29.23 | $292,330.00 | -10.0% | -12.8% | -1.3% | |
| Apr 25, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $27.88 | $278,849.00 | -10.0% | +2.0% | +7.2% | |
| Apr 20, 2022 | Jackson Blair Curtis | EVP, Chief Operating Officer | Sale+OE | 49,999 | $29.61 | $1,480,335.39 | -36.3% | +1.1% | -1.5% | |
| Apr 18, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $28.88 | $288,750.00 | -10.0% | +1.7% | +1.2% | |
| Apr 11, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $29.26 | $292,601.00 | -10.0% | +7.7% | +0.5% | |
| Apr 4, 2022 | Cooke Shane62 | Director | Sale+OE | 10,000 | $28.18 | $281,845.00 | -10.0% | +9.5% | +1.4% | |
| Mar 4, 2022 | Snyderman Nancy Lynn Md | Director | Buy | 427 | $23.43 | $10,004.61 | +4.8% | +28.3% | +17.6% | |
| Feb 23, 2022 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 11,983 | $24.76 | $296,649.95 | -40.0% | +17.5% | +13.4% |